Table 2.
The expression of noradrenergic markers in adult human sympathetic ganglia
| SCG | MCG | STG | Thoracic | Sacral | ||
|---|---|---|---|---|---|---|
| TH | 83.8% | 59.3% | 70.4% | (Kokubun et al. 2019) | ||
| 75% | (Schalling et al. 1989) | |||||
| > 75% | (Tajti et al. 1999) | |||||
| 90% | (Takenaka et al. 2005) | |||||
| Virt. all | (Kirch et al. 1995) | |||||
| Rich | (Baffi et al. 1992) | |||||
| DBH | 91% | 92.1% | 94.2% | (Kokubun et al. 2019) | ||
| 75% | (Schalling et al. 1989) | |||||
| Virt. all | (Kirch et al. 1995) | |||||
| Similar to TH | (Baffi et al. 1992) |
The proportion of neurons immunopositive for the noradrenergic marker enzymes TH and DBH for different human cervical and paravertebral sympathetic ganglia are provided
SCG, superior cervical ganglion; MCG, middle cervical ganglion; STG, stellate ganglion. Virt. all indicates that virtually all neurons are positive; rich indicates a rich supply of positive neurons; similar TH indicates that the number of DBH and TH-positive cells are similar as expected for cells co-expressing the noradrenergic marker enzymes